Skip to main content

Digital Pathology Market to Surpass USD 2067.36 Million by 2031, Witnessing 7.8% CAGR Growth | SkyQuest Technology

Westford, USA, Sept. 12, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Global Digital Pathology Market will reach a value of USD 2067.36 Billion by 2031, with a CAGR of 7.8% during the forecast period (2024-2031).

Due to the increasing number of cancer cases, there is more focus on improving work efficiency while quick diagnostic tools are becoming a necessity. Additionally, the market is growing due to rising investments in healthcare, which are supported by major players in the industry that concentrate on new launches, growing telepathology adoption, and a growing emphasis on precision medicine and drug discovery. The market for digital pathology solutions is being driven by the increasing adoption of healthcare IT solutions.

Get a Free Sample Research Report:
https://www.skyquestt.com/sample-request/digital-pathology-market

Digital Pathology Market Segmental Analysis

Global Digital Pathology Market is segmented based on product, application, and region. 
Based on product, the market is segmented into Software {by type [integrated and standalone (information management system and image analysis software)], by deployment mode (on premises and cloud based), scanners (brightfield scanners and other scanners), device, and storage systems. 
By application, the market is segmented into drug discovery & development, academic research, and disease diagnosis. 
By type, the market is segmented into human pathology and veterinary pathology. 
By end use it is segmented into pharmaceutical and biotechnology, Hospitals & Reference Laboratories, Academic & Research Institutes. 
By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Digital Pathology Market Overview:

Report CoverageDetails
Market Revenue in 2023USD 1133.61 Billion
Estimated Value by 2031USD 2067.36 Billion
Growth RatePoised to grow at a CAGR of 7.8%
Forecast Period2024–2031
Forecast UnitsValue (USD Billion)
Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments CoveredProduct, Application, Type, End User and Region
Geographies CoveredNorth America, Europe, Asia-Pacific, Latin America, and Middle East and Africa
Report HighlightsTelepathology and remote consultation
Key Market OpportunitiesAI and Machine learning applications
Key Market DriversNeed for efficient workflow and collaboration

Ask for Customization:
https://www.skyquestt.com/speak-with-analyst/digital-pathology-market

Prominent Players in Digital Pathology Market

  • Philips Healthcare (Netherlands) 
  • Roche Diagnostics (Switzerland) 
  • Hamamatsu Photonics (Japan) 
  • 3DHISTECH (Hungary) 
  • GE Healthcare (US) 
  • Apollo Enterprise Imaging (US) 
  • Olympus Corporation (Japan) 
  • Mikroscan Technologies (US) 
  • Inspirata (US) 
  • PerkinElmer (US) 
  • Huron Digital Pathology (Canada) 
  • Sectra AB (Sweden) 
  • PathAI (US) 
  • Indica Labs (US) 
  • F. Hoffmann-La Roche (Switzerland) 
  • Nikon Corporation (Japan)

Device Product Segment to Hold Significant Growth Due to Advancements in Imaging Systems

Endorsed by progressions in AI-accommodating therapeutics instruments, imaging schemes and scanners, gadget offerings run the global digital pathology industry presently. Thus, pathology slides can be analyzed with swifter speeds and higher accuracies; this way enhancing both clinical procedures as well as diagnostic correctness. As a result, these innovations are widely adopted in patient care, education, and research, propelling market expansion.

Academic Research to Lead Market Due to Cutting-Edge Studies on AI-Driven Diagnostics

Cutting-edge studies on AI-driven diagnostics, machine learning algorithms, and data analytics are driving innovation in the global digital pathology market. These studies are conducted by academic institutions. This industry leads because of its contributions to the creation of new technologies, the advancement of precision medicine, and the creation of partnerships that push the frontiers of digital pathology for use in clinical and research settings.

North America to Dominate the Market Due to Rising Adoption of Digital Imaging

The global market for digital pathology was led by North America. This can be ascribed to a number of things, such as growing government initiatives to develop technologically complex pathologies, ongoing investments in R&D, the increasing use of digital imaging, and the existence of significant market players in the region.

Take Action Now: Secure Your Digital Pathology Market Today – https://www.skyquestt.com/buy-now/digital-pathology-market

Digital Pathology Market Insight

Drivers:

  1. Rising Demand for Accurate and Early Diagnosis
  2. Advancements in Digital Imaging Technologies
  3. Growing Adoption of AI and Machine Learning in Pathology

Restraints:

  1. High Maintenance Costs
  2. Regulatory and Standardization Challenges
  3. Limited Integration with Existing Laboratory Systems

Key Questions Answered in Global Digital Pathology Market Report

  • By 2031, how much is the global digital pathology market expected to be worth?
  • Which region is now leading the world market for digital pathology, and why?
  • Which major factors are propelling the digital pathology market expansion?

This report provides the following insights:

  • Analysis of key drivers (Increasing cases of chronic diseases, high-resolution scanners, Automated analysis improves diagnostic accuracy), restraints (Shortage of pathologists trained to use digital pathology tools, raising issues related to cybersecurity, approval processes being time-consuming), opportunities (Expansion of AI-driven diagnostic tools, global push towards telehealth, Increased focus on oncology and precision medicine), and challenges (Privacy laws like GDPR and HIPAA pose challenges, Limited healthcare infrastructure in low- & middle-income countries) influencing the growth of digital pathology market.
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the digital pathology market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the digital pathology market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

Related Reports:
Hemp Market is growing at a CAGR of 14.04% during the forecast period (2024-2031).
Smart Inhalers Market is growing at a CAGR of 19.8% during the forecast period (2024-2031).
Medical Waste Management Market is growing at a CAGR of 6.2% in the forecast period (2024-2031).
Herbal Medicine Market is growing at a CAGR of 11.16% in the forecast period (2024-2031).
Medical Supplies Market is growing at a CAGR of 3.8% during the forecast period (2024-2031).

About Us:

SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.

We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.

Contact:

Mr. Jagraj Singh

SkyQuest Technology

1 Apache Way,

Westford,

Massachusetts 01886

USA (+1) 351-333-4748

Email: sales@skyquestt.com

Visit Our Website: https://www.skyquestt.com/

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.